Jorge Velarde
About Jorge Velarde
Chief Business Officer at Singular Genomics
Jorge Velarde holds the position of Chief Business Officer at Singular Genomics. Since joining the company, he has been instrumental in establishing the commercial organization. His role includes overseeing corporate development and strategy, where he contributes his extensive experience in genomics and clinical diagnostics to drive the company forward.
Career at Illumina
Jorge Velarde played a significant role at Illumina, where he served as Vice President for over a decade. In this position, he was responsible for leading corporate and business development, as well as managing alliances. His contributions were pivotal during his tenure, helping to shape the company's direction in the genomics sector.
Early Contributions at Gen-Probe
As one of the early employees at Gen-Probe, Jorge Velarde played a key role in business development. He was involved in the commercialization of DNA probe diagnostics for blood banks and clinical laboratories on a global scale, significantly contributing to the company's growth and success in the diagnostics industry.
Scientific Co-Founder of Chugai Biopharmaceuticals
Jorge Velarde co-founded Chugai Biopharmaceuticals and was the co-inventor of an HIV drug that went into human clinical trials. His scientific expertise and entrepreneurial spirit underscored his role in bringing innovative solutions to the market, highlighting his impact on biopharmaceutical advancements.
Board Member at Kura Biotech
Currently, Jorge Velarde serves on the board of Kura Biotech, a company specializing in toxicology and diagnostics. His extensive background in both business and science provides valuable insights and guidance, supporting Kura Biotech's mission and strategic goals in the diagnostics field.
Educational Background
Jorge Velarde received his MBA from the Paul Merage School of Business at the University of California, Irvine. He also holds a Bachelor of Science degree in Molecular Biology from Loyola University. His educational foundation supports his extensive expertise in business development, strategy, and the life sciences.